According to a recent study in the Journal of the National Cancer Institute, the evidence continues to mount for an association between breastfeeding and reduced risk of aggressive breast cancers in African-American women.
According to a recent study in the Journal of the National Cancer Institute, the evidence continues to mount for an association between breastfeeding and reduced risk of aggressive breast cancers in African-American women.
Led by researchers at the Roswell Park Cancer Institute, the study used questionnaire data from 2 cohort and 2 case-control studies of breast cancer in African-American women, which was subsequently combined and harmonized. Based on pathology data, breast cancer in respondents was classified as estrogen receptor-positive (ER+) (n = 2446), ER- (1252), or triple negative (ER-, progesterone receptor-negative [PR-], HER2-negative; n =567). There were 14180 control patients overall. Adjusting for study, age, and reproductive and other risk factors, polytomous logistic regression analysis was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs).
Stat bite: Preconception health indicators
For parity relative to nulliparity, the ORs were 0.92 (95% CI = 0.81 to 1.03) for ER+ disease, 1.33 (95% CI = 1.11 to 1.59) for ER-, and 1.37 (95% CI = 1.06 to 1.70) for triple-negative breast cancer. Breastfeeding was associated with ER- breast cancer (OR = 0.81, 95% CI 0.69 to 0.95), but not with ER+ cancer. The risk of ER- breast cancer increased with each additional birth in which the child was not subsequently breastfed, an OR of 1.68 (95% CI = 1.15 to 2.44) for 4 or more births compared to 1 birth with breastfeeding.
The investigators concluded that parous African-American women who did not breastfeed were at an increased risk of triple negative and ER- breast cancers.
To get weekly advice for today's Ob/Gyn, subscribe to the Contemporary OB/GYN Special Delivery.
Postmenopausal urinary incontinence treatment data found lacking
May 6th 2024Discover the findings of a comprehensive study exploring the efficacy of various treatments for postmenopausal urinary incontinence, shedding light on the current research gap and recommending avenues for future investigation.
Read More
Pioglitazone outperforms metformin in IVF for PCOS-related infertility
May 6th 2024A recent double-blind, randomized clinical trial revealed a higher clinical pregnancy rate with pioglitazone compared to metformin in polycystic ovarian syndrome patients undergoing in vitro fertilization, suggesting potential for improved outcomes.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More
Postmenopausal urinary incontinence treatment data found lacking
May 6th 2024Discover the findings of a comprehensive study exploring the efficacy of various treatments for postmenopausal urinary incontinence, shedding light on the current research gap and recommending avenues for future investigation.
Read More
Pioglitazone outperforms metformin in IVF for PCOS-related infertility
May 6th 2024A recent double-blind, randomized clinical trial revealed a higher clinical pregnancy rate with pioglitazone compared to metformin in polycystic ovarian syndrome patients undergoing in vitro fertilization, suggesting potential for improved outcomes.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More
2 Commerce Drive
Cranbury, NJ 08512